Meridiem Capital Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-226,542
Closed -$42.4M – 126
2026
Q2
$42.4M Buy
226,542
+46,059
+26% +$8.47M 1.9% 15
2026
Q1
$34.1M Buy
180,483
+154,632
+598% +$32.6M 2.22% 15
2025
Q4
$5.14M Buy
+25,851
New +$5.22M 0.31% 64
2025
Q1
– Sell
-23,427
Closed -$2.96M – 93
2024
Q4
$2.96M Buy
+23,427
New +$3.48M 0.26% 63

Other funds holding THC

Meridiem Capital Partners's THC Position: Q3 2026 in Review

Meridiem Capital Partners sold out of Tenet Healthcare (THC) in Q3 2026, closing a stake of 226,542 shares — an estimated $42.4M sold.

Meridiem Capital Partners first reported a position in THC in Q4 2024 and held it in 4 quarters. The position peaked at $42.4M in Q2 2026. 783 funds tracked by Wall St. Rank hold THC as of Q3 2026.

  • Meridiem Capital Partners reported no remaining Tenet Healthcare position as of Q3 2026 after selling out during the quarter.
  • Meridiem Capital Partners sold 226,542 Tenet Healthcare shares in Q3 2026, an estimated $42.4M.
  • Meridiem Capital Partners first reported a position in Tenet Healthcare in Q4 2024 and held it in 4 quarters.
  • Meridiem Capital Partners's Tenet Healthcare position peaked at $42.4M in Q2 2026.
  • 783 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2026.

Based on Meridiem Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.